Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 6,350.00
-80.00 (-1.24%)
At close: Oct 2, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 53.43 billion as of October 2, 2026. Its market cap has decreased by -44.86% in one year.
Market Cap
53.43B
Enterprise Value
-36.16B
Revenue
107.87B
Ranking
n/a
PE Ratio
13.38
Stock Price
6,350.00
ChartMarket Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 53.43B, an increase of 116.53%. That is a compound annual growth rate of 3.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 53.43B | -45.01% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaris AI Pharma | 73.46B |
| Sinil Pharmaceutical | 73.26B |
| Sinsin Pharmaceutical | 67.28B |
| Optipharm.CO.,LTD | 66.16B |
| GL Pharm Tech | 66.07B |
| BL Pharmtech | 59.31B |
| RP Bio | 51.48B |
| Jin Yang Pharmaceutical | 51.19B |